Thrivent Financial for Lutherans’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$814K Buy
34,049
+134
+0.4% +$3.2K ﹤0.01% 1913
2025
Q1
$843K Sell
33,915
-1,774
-5% -$44.1K ﹤0.01% 1826
2024
Q4
$672K Sell
35,689
-534
-1% -$10.1K ﹤0.01% 2126
2024
Q3
$545K Sell
36,223
-2,417
-6% -$36.4K ﹤0.01% 2218
2024
Q2
$1.11M Sell
38,640
-28,224
-42% -$807K ﹤0.01% 1819
2024
Q1
$1.95M Sell
66,864
-11,047
-14% -$323K ﹤0.01% 1438
2023
Q4
$2.63M Sell
77,911
-13,847
-15% -$467K 0.01% 1194
2023
Q3
$2.82M Buy
91,758
+47,764
+109% +$1.47M 0.01% 1067
2023
Q2
$1.76M Sell
43,994
-1,476
-3% -$59.1K ﹤0.01% 1425
2023
Q1
$1.86M Sell
45,470
-1,593
-3% -$65K ﹤0.01% 1347
2022
Q4
$1.82M Sell
47,063
-306
-0.6% -$11.8K ﹤0.01% 1319
2022
Q3
$2.52M Buy
47,369
+2,730
+6% +$145K 0.01% 1092
2022
Q2
$2.6M Buy
44,639
+8,377
+23% +$488K 0.01% 1086
2022
Q1
$2.77M Buy
36,262
+12
+0% +$916 0.01% 1141
2021
Q4
$2.18M Buy
36,250
+317
+0.9% +$19.1K ﹤0.01% 1334
2021
Q3
$2.01M Sell
35,933
-57
-0.2% -$3.19K ﹤0.01% 1349
2021
Q2
$2.18M Sell
35,990
-42
-0.1% -$2.55K ﹤0.01% 1368
2021
Q1
$2.53M Buy
36,032
+72
+0.2% +$5.05K 0.01% 1267
2020
Q4
$2.15M Buy
35,960
+519
+1% +$31.1K 0.01% 1274
2020
Q3
$2.13M Buy
35,441
+185
+0.5% +$11.1K 0.01% 1121
2020
Q2
$1.85M Buy
35,256
+282
+0.8% +$14.8K 0.01% 1114
2020
Q1
$1.17M Buy
34,974
+1,746
+5% +$58.6K ﹤0.01% 1207
2019
Q4
$1.51M Buy
33,228
+226
+0.7% +$10.2K ﹤0.01% 1197
2019
Q3
$1.26M Buy
+33,002
New +$1.26M ﹤0.01% 1262
2017
Q2
Sell
-38,653
Closed -$1.76M 2062
2017
Q1
$1.76M Buy
+38,653
New +$1.76M 0.01% 903